UBL3 and breast carcinoma: When we examined the association of newly identified markers with overall Asian cases including late-onset and sporadic breast cancers of BCAC, both rs11154838 (PDE7B) and rs78545330 (CDKN2B-AS1) showed stronger level of significance but with smaller effect sizes (ORs: 1.16 and 1.14 for all breast cancers, 1.26 and 1.19 for high-risk breast cancers), but rs278050 (UBL3) was not associated (p = 0.2).